Evidence mapPaperPMID 42418583Full record

ArticleScience advances2026

Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment.

Wenyan She, Xiaojuan Jiang, Siying Deng, Luyuan Hu, Chenxi Huang, Lin Hou

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenyan SheSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0001-7580-4036
Xiaojuan JiangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0009-0006-5605-1132
Siying DengSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Luyuan HuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Chenxi HuangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Lin HouSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0001-7914-3749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus remains a global health challenge, as current insulin-based therapies merely control blood glucose without restoring islet β cell function, leaving patients dependent on lifelong medication and vulnerable to hypoglycemia. Antioxidant drugs hold promise for islet β cell repair but are limited by poor gastrointestinal transportation and insufficient pancreatic targetability. Here, we initially identify ferroptosis-associated oxidative stress as a key cause of islet β cell death and develop six stiffness-gradient nanoparticles by embedding bent oleic acid into ordered 1,2-distearoyl-

Indexed as

Diabetes Mellitus, ExperimentalInsulin-Secreting CellsNanoparticlesAdministration, OralAnimalsCurcuminHumansHypoglycemic AgentsInsulinMiceOxidative StressCurcuminHypoglycemic AgentsInsulin

Identifiers

PMID42418583
PMCPMC13344296

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.